Andrew J. Cutler, MD

Chief Medical Officer
Neuroscience Education Institute, and Clinical Associate Professor of PsychiatrySUNY Upstate Medical University

Abstracts(s):

• PC3019: Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) Optimized Dose Levels and Effects on Attention-deficit/hyperactivity Disorder-rating scale-5 (ADHD-RS-5) Response Rates in Children with ADHD
  Monday, October 10, 2022

  1:30 PM – 2:30 PM US PDT